Carlos Rodriguez-Galindo, MD, chair of the Department of Global Pediatric Medicine and director of the International Outreach Program at St. Jude Children’s Research Hospital, and chair of the rare tumor committee at the Children’s Oncology Group, talks about the role rare cancer research has in advancing cancer care as a whole.

Rodriguez-Galindo feels that someone with a rare cancer has the same rights as someone with a common cancer, meaning access to research and experts. With pediatric cancers already facing disparities, if researchers want to advance the fight against cancer, it must be done on all fronts. Also, Rodrigues-Galindo says that there is a lot that can be learned from rare cancers to help in this fight.

Videos

Carlos Rodriguez-Galindo, MD, chair of the Department of Global Pediatric Medicine and director of the International Outreach Program at St. Jude Children’s Research Hospital, and chair of the rare tumor committee at the Children’s Oncology Group, talks about the role rare cancer research has in advancing cancer care as a whole.
 

Carlos Rodriguez-Galindo Discusses Rare Cancer Research

Carlos Rodriguez-Galindo, MD, chair of the Department of Global Pediatric Medicine and director of the International Outreach Program at St. Jude Children’s Research Hospital, and chair of the rare tumor committee at the Children’s Oncology Group, discusses treating rare pediatric cancers.

Pediatric cancer makes up only about 1% of all cancers, so rare pediatric cancer types, such as liver tumors, germ cell tumors, and carcinomas are particularly difficult to treat because research is lagging due to their small numbers. So, about ten years ago, the Children’s Oncology Group established a committee that would focus solely on rare tumor types, leading to multiple clinical trials and advancements.

Carlos Rodriguez-Galindo, MD

Articles

Carlos Rodriguez-Galindo Discusses Rare Cancer Research

Carlos Rodriguez-Galindo on Treating Rare Pediatric Cancer